---
title: "688302.SH (688302.SH) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/688302.SH/news.md"
symbol: "688302.SH"
name: "688302.SH"
parent: "https://longbridge.com/en/quote/688302.SH.md"
datetime: "2026-05-20T19:09:26.642Z"
locales:
  - [en](https://longbridge.com/en/quote/688302.SH/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/688302.SH/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/688302.SH/news.md)
---

# 688302.SH (688302.SH) — Related News

### [Directly hitting the Hinova shareholder meeting: Haina'an's sales network has covered the entire country, and the company may achieve breakeven by 2028](https://longbridge.com/en/news/286985066.md)
*2026-05-20T01:08:11.000Z*
> Hinova stated at the shareholders' meeting that its first self-developed drug, Haina'an, has been rolled out nationwide 

### [Observation of Gross Profit Margins in Pharmaceutical Stocks: 14 Stocks Exceed Kweichow Moutai, Hinova Tops with 98.62%](https://longbridge.com/en/news/285957803.md)
*2026-05-11T13:55:10.000Z*
> With the disclosure of the 2025 annual report, the gross profit margins of A-share pharmaceutical stocks have attracted 

### [A-share gross profit margin ranking: Biopharmaceuticals and beauty care dominate, with 22 companies surpassing Kweichow Moutai](https://longbridge.com/en/news/285365920.md)
*2026-05-06T11:13:13.000Z*
> The average sales gross margin of A-share listed companies in 2025 is 27.22%, a slight decrease of 0.41 percentage point

### [688302, with a gross profit margin exceeding 98%! Only 4 stocks have a return on total assets exceeding 30% for three consecutive years!](https://longbridge.com/en/news/284985413.md)
*2026-05-03T06:14:40.000Z*
> The 2025 A-share annual report disclosure has concluded. This article focuses on two core profitability hard indicators:

### [A-share 2025 Sales Gross Margin Ranking: Pharmaceutical Biology and Computer Industries Dominate](https://longbridge.com/en/news/284984638.md)
*2026-05-03T05:36:49.000Z*
> The 2025 annual report of A-shares shows that the sales gross margin of the beauty care and food and beverage industries

### [Hinova: HP515 Phase IIa clinical trial achieves interim analysis results](https://longbridge.com/en/news/284189497.md)
*2026-04-27T09:52:03.000Z*
> Hinova announced that its self-developed HP515 achieved positive interim analysis results in the clinical Phase IIa tria

### [2025 A-share Annual Report Panorama Decoding: High-quality Tracks Concentrated Explosion with Over 350 Companies Doubling Their Net Profit Attributable to Shareholders](https://longbridge.com/en/news/283469411.md)
*2026-04-21T09:09:13.000Z*
> In 2025, the overall performance of A-share listed companies is positive, with over 60% of companies achieving positive 

### [A-share closing review: The three major indices collectively fell, motorcycle concept stocks showed volatility in the afternoon, and "Zhang Xue Motorcycle" concept stock HC had a 20% limit up for two consecutive days](https://longbridge.com/en/news/281141243.md)
*2026-03-31T07:17:17.000Z*
> On March 31, the three major A-share indices collectively fell, with the Shanghai Composite Index down 0.8%, the Shenzhe

### [Shanghai Composite Nears Positive Territory, Pharmaceutical Stocks Surge, Computing Hardware Stocks Continue to Adjust, HSI Fluctuates Higher, New Consumption Concept Stocks Rebound, POP MART Rises 2%](https://longbridge.com/en/news/280715251.md)
*2026-03-27T08:46:11.000Z*
> Innovative drug concept stocks showed active performance, with JLPC touching the daily limit, Menovo hitting 5 daily lim